first_img Best caption wins🏆 Credit @4×4 Rebekah Vardy scores an impressive penalty in six-inch heels MANCHESTER UNITED youngster Aliou Traore has completed a season-long loan deal to join French side SM Caen.The Red Devils teenager has headed back to his homeland in search of regular first-team football with the Ligue 2 outfit.Manchester United youngster Aliou Traore has joined French side SM Caen on loanCredit: Getty Images – GettyThe 19-year-old Frenchman can play either in central midfield or in wide areas.He has impressed since his 2017 move from Paris Saint-Germain and scored four goals in 14 appearances for United U23s as they earned promotion last season.Traore will wear the number 15 shirt at Caen, who finished 13th in France’s second division last term after being relegated from Ligue 1 in 2019.The highly-rated youngster is yet to feature for United’s first-team and recently admitted he was ready to make the jump.Traore told RMC Sport: “I have become a more complete player in three years. “I have put on a fair amount of muscle and I am stronger physically, I have become better tactically…I think that I am a player who is ready for professional football.“In terms of how I have progressed, I am happy with my three years. But at the same time I imagined that I would already be a bit further ahead. Playing and training more regularly with the first-team squad.“Now, these three years must enable me to play at the professional level. I’ve acquired a background at the youth academy in Manchester that I want to use at a higher level now.“I hope that happens in Manchester, if not then why not go and get playing time elsewhere. But if I leave, it is for a first team. I do not want to leave Manchester to be in the same situation elsewhere.”Traore has become the latest United youngster to leave Old Trafford this summer.Tahith Chong is training with Werder Bremen ahead of his expected loan move to the Bundesliga next season.While Angel Gomes joined Lille on a permanent deal before he was immediately loaned back out to Portuguese side Boavista.Ole Gunnar Solskjaer says he ‘can’t fault the boys’ despite slew of missed chances in Europa League quarter and semi-finals Football player touch female referee s breast! Source: Soccer – thesun.co.uk Most awesome bullfighting festivalcenter_img REAL vs FAKE GOLD People Slammed By Massive Waves 4 10 INCREDIBLE Space Launch Failures! Travel Diary // Vietnam 2017last_img read more

first_imgMike Lineberry was the hard charger in his first trip this season to Boone Speedway.He’d like to qualify for the Modified main event at the IMCA Speedway Motors Super Nationals fueled by Casey’s in his second.From Fremont, Neb., Lineberry isn’t sure how many times he’s raced at Super Nationals … it’s somewhere between eight and 10 … and like all drivers, taking the green in the Saturday show would be a career highlight.“Super Nationals is a good time. You get to see a lot of people you haven’t seen for a while,” he said. “I’ve never made the show. I’d like to do it once.”A pavement specialist – Lineberry runs a concrete plant – followed the Arizona Modified Tour early in 2018. He ran Saturdays at Eagle Raceway and was the $100 hard charger winner when he came to Boone Speedway to get some laps in a couple weeks ago.last_img read more

first_imgMost people are aware of the need for captions to make videos more accessible. But few are familiar with the requirement for audio description for videos, which accommodates people who are blind or have low-vision. Audio description narrates what visually is happening in the video, information that’s not available to someone who can’t see. Think of a radio sports announcer at a baseball game, describing the ground ball hit to the third baseman who throws the ball to the second baseman for the beginning of a double play. That’s similar to audio description. Intro to Audio Description for VideosOn Thursday, January 17, 2019, you can learn more about video audio description when 3Play Media hosts their free Intro to Audio Description webinar at 2:00pm Eastern Time. In the one-hour webinar, Sofia Leivaf from 3Play Media, will highlight the basics of audio description:What is audio description?How to add audio description to online videoVideo player compatibility: which players support itLegal requirements: accessibility laws and complianceHow to create and publish it on your ownDifference between standard and extended audio descriptionWhat tools and features can make it easier to produce audio descriptionAfter the presentation, Leiva will take answer questions from webinar attendees.Who is the Audience for the Webinar?Anyone looking to make their videos more accessible, and those taking the next step beyond captioning their videos, will find useful information and help from the webinar. Wrapping UpIncluding audio description with your captioned video will make your video content more accessible; you’ll reach a wider audience. The free 3Play Media webinar will provide the background and knowledge you need to move forward and add audio descriptions to your videos. I hope you’ll join me on Thursday, January 17, 2019 and register for the free 3Play Media webinar. I’ll be live tweeting during the webinar!Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window)Like this:Like Loading…RelatedKey Takeaways from HTML5 Video AccessibilityLast week I attended the HTML5 Video Accessibility: Updates, Features & Guidelines webinar from 3Play Media. Guest speaker John Foliot, W3C contributor and accessibility expert at Deque Systems, discussed guidelines for making videos accessible and shared his tips and insights on HTML5 video. Check out the recording of the webinar…In “Accessibility”Free Webinar: Planning and Producing Accessible Videos for Web, Social Media, and eLearningYou’re invited to the Great Lakes Americans with Disabilities Act (ADA) Center free webinar on July 20, 2017, focusing on planning and producing accessible video. The Planning and Producing Accessible Videos for Web, Social Media, and eLearning webinar will teach you the key components needed to produce videos that are…In “Accessibility”DescribeAthon17: Make Video on YouTube More AccessibleI invite you to join me tomorrow, January 26, 2017 at DescribeAthon17 when amateur and professional describers around the world will join together to add audio descriptions to YouTube videos. Working from your home, business, or wherever you have a connection to the Internet, you’ll be part of a group…In “Accessibility”last_img read more

first_imgAt Intel, we’re always looking for feedback on the way IT should be. Therefore, at the recent MMS 2008 Conference, we had Intel customers, partners, and technical experts from Microsoft and Intel tell us their meaning of IT Utopia.

To see more videos from MMS 08, go to http://www.intel.com/go/mms/last_img

first_img The massive amount of dysfunction and paperwork that will result from this decision boggles the mind. Nancy Kanwisher, Massachusetts Institute of Technology By Jocelyn KaiserJul. 19, 2017 , 1:00 PM © Vassar College/Karl Rabe NIH says it is too soon to know whether the agency will ultimately define Kanwisher’s study and others like it as clinical trials. Still, “it’s fair to say there are probably going to be more [studies] under the clinical trial definition than we have seen previously,” says NIH Acting Chief of Staff Carrie Wolinetz. But, she adds, “it is going to be less than some in the community are anticipating.”The policy change began to emerge in 2014, when NIH revised its definition of clinical trials to include studies that evaluate the effects of “interventions” such as “manipulation … of the subject’s environment” on “health-related biomedical or behavioral outcomes.” Then, last September, NIH announced more extensive requirements for all trials the agency funds. For example, it mandated new training for trial staff as well as registration and results reporting on clinicaltrials.gov. The agency also said research projects that fit the definition could only receive NIH backing in response to a formal funding opportunity announcement (FOA) for trials, and that all such applications would be sent to a clinical trial review group, which would assess the study’s rationale and statistical design. Under new rules, basic studies of how the brain processes images could be redefined as clinical trials. Some scientists hate NIH’s new definition of a clinical trial. Here’s why Nancy Kanwisher, a cognitive neuroscientist, has spent her career pinning down how the human brain responds to visual inputs such as faces. As part of that work, Kanwisher asks volunteers—usually college students at the Massachusetts Institute of Technology (MIT) in Cambridge, where she works—to lie in an MRI machine that records their brain activity while they do a task, such as viewing a photo. Although such studies reveal information that can be relevant to diseases, and disorders such as autism, they do not test treatments.But a few weeks ago, Kanwisher and colleagues in related behavioral research fields—from cognitive psychology to vision science—were dismayed to learn that the U.S. National Institutes of Health (NIH) in Bethesda, Maryland, could soon deem their studies to be clinical trials. That designation would impose a raft of new requirements on studies that have already passed ethics review, such as following different standards for funding applications, and reporting results on clinicaltrials.gov, a public database.NIH officials say they simply want to ensure that all clinical trials—including those testing drugs, medical devices, and behavioral interventions—meet recently bolstered standards for rigor and transparency. But Kanwisher and others say that the agency’s widening definition of clinical trials could sweep up a broad array of basic science studies, resulting in wasted resources and public confusion. “The massive amount of dysfunction and paperwork that will result from this decision boggles the mind” and will hobble basic research, Kanwisher says. To prevent that outcome, she and dozens of other researchers, along with several scientific societies, have flooded NIH with letters and emails expressing concern about the policy, which the agency announced last September but is only now implementing.Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*) Few basic behavioral and brain researchers who study humans took notice of the change, because they didn’t think of their studies as clinical trials. But that changed early last month, after William Riley, director of the NIH Office of Behavioral and Social Sciences Research, gave a talk to the behavioral sciences board at the National Academy of Sciences in Washington, D.C. Riley warned that many studies in disciplines under his office’s purview could fall under the new policy, which kicks in with applications submitted in January 2018.The remarks sparked fierce pushback. In a 6 June letter to NIH, the Association for Psychological Science (APS) in Washington, D.C., argued that the agency’s definition of an intervention “is exceptionally broad and appears to encompass any manipulation of a variable hypothesized to have an impact on a measured behavioral outcome.” APS also worries that many researchers may not be aware of the new FOA requirement, leading NIH to reject their applications and forcing them to miss a funding cycle. And it fears that applications that do reach a review may suffer, because the criteria traditionally used to evaluate a clinical trial might not apply to the proposed research.Similar “serious concerns” were voiced by the Federation of Associations in Behavioral & Brain Sciences (FABBS) in Washington, D.C., which represents 20 scientific societies, in a 12 July letter asking NIH to pause the policy and gather more feedback. Among other fears, FABBS members worry that researchers will be required to report any added experiment as a new protocol on clinicaltrials.gov—something not usually required in basic research. “It would bureaucratize the science in a way that would cripple exploratory research,” says Harvard University cognitive psychologist Jeremy Wolfe, FABBS president.The FABBS letter also predicts that including a wider range of studies on clinicaltrials.gov, which many patients use to find trials that are seeking participants, will confuse the public by clogging the database with irrelevant studies. Although the policy might help address the “file drawer problem” in psychology and neuroscience—the failure to report negative results—using clinicaltrials.gov as a solution may do more harm than good, Wolfe says.Wolinetz says NIH has “heard the concerns,” which are also being voiced by leaders at some NIH institutes, and is working to clarify the scope of the definition. “We’re not out to harm our grantee community in any way here,” she says, adding that “our interpretation is evolving as we recognize areas that are ambiguous.” The agency expects to offer guidance within a few months on which behavioral studies will now be called clinical trials.*Clarification, 31 July, 6:53 p.m.: This story originally characterized autism as a disease, although it is generally classified as a neurodevelopmental disorder.last_img read more